|
MTOR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.866200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.245800E-01 |
| Normal-vs-Stage2 |
6.027000E-01 |
| Normal-vs-Stage3 |
9.237700E-02 |
| Normal-vs-Stage4 |
6.388200E-02 |
| Stage1-vs-Stage2 |
5.002600E-01 |
| Stage1-vs-Stage3 |
5.497900E-02 |
| Stage1-vs-Stage4 |
3.647900E-02 |
| Stage2-vs-Stage3 |
6.781800E-02 |
| Stage2-vs-Stage4 |
5.779900E-02 |
| Stage3-vs-Stage4 |
8.420200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.818000E-01 |
| Normal-vs-AfricanAmerican |
9.645000E-01 |
| Normal-vs-Asian |
9.839200E-01 |
| Caucasian-vs-AfricanAmerican |
5.006000E-01 |
| Caucasian-vs-Asian |
5.431400E-01 |
| AfricanAmerican-vs-Asian |
9.595400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.934200E-01 |
| Normal-vs-Female |
3.867000E-01 |
| Male-vs-Female |
4.490600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.695400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.568750E-01 |
| Normal-vs-Age(61-80Yrs) |
6.490000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.458800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.019800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.772600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.729200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.767000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.134600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.581800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.847500E-02 |
| Classical-VS-Follicular |
1.067660E-02 |
| Classical-VS-Other |
2.545400E-01 |
| Classical-VS-Normal |
6.495200E-01 |
| Tall-VS-Follicular |
8.875600E-01 |
| Tall-VS-Other |
8.212400E-01 |
| Tall-VS-Normal |
1.175160E-01 |
| Follicular-VS-Other |
7.846200E-01 |
| Follicular-VS-Normal |
9.446100E-02 |
| Other-VS-Normal |
2.185400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.929400E-01 |
| Normal-vs-N1 |
1.225390E-01 |
| N0-vs-N1 |
3.104400E-01 |
|
|
